Almac has more than doubled existing capacity of its 2-8°C clinical supply labeling cold room facilities at the Group’s Craigavon, UK, Souderton, PA, and Durham, NC headquarter sites.
 
Additional dedicated temperature and humidity controlled labelling suites are now live, increasing capacity to label temperature sensitive investigational products, including biosimilar and biological investigational products.
  
Commenting on this latest expansion, Robert Dunlop, managing director of Almac’s Clinical Services Business Unit said, “We have witnessed significant growth in the biologics market in the past 12 months and this latest investment reflects both our on-going commitment to meeting the demands of the clinical trial market, as well as our ability to expand and adapt successfully to key developments within the pharmaceutical and biotech industries. These are exciting times for Almac as we continue to increase our range of services to deliver world class solutions to our global client base.”